At Biohaven, being patient-centric means ensuring transparency.
Biohaven is committed to transparency for our clinical trials with patients and researchers to advance science and improve awareness. Furthermore, we commit to sharing clinical trial results, regardless of outcome, on applicable registries in accordance with the law.
We commit to the registration of all Phase II-IV interventional trials on applicable registries, like www.clinicaltrials.gov, prior to the first patient being enrolled. We also commit to register Ph I interventional studies in accordance with international and national disclosure requirements for the countries in which we conduct research.
We commit to sharing clinical trial summary results on company-sponsored studies in compliance with applicable international and national disclosure requirements and timelines. Results may be available, for example, on websites such as www.clinicaltrials.gov, published in peer-reviewed journals, or presented at scientific meetings or congresses.